Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1P50MH119029-01A1 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Rush University | OTHER |
| National Institute of Mental Health (NIMH) | NIH |
Not provided
Not provided
Not provided
Not provided
This study will compare two digital mental health interventions (DMHIs). One DMHI will use an app called Vira (which is a product developed and managed by Ksana Health), along with low intensity coaching provided via phone and both SMS text and in-app messaging. The other DMHI will provide a broad range of information on how to manage symptoms of depression, anxiety, and stress. The DMHI will be evaluated with patients receiving care from Rush University Medical Center's primary care and family medicine clinics, which serve racially, ethnically, and economically diverse communities; evaluations may also be extended beyond Rush patients.
Depression and anxiety are common and impose a tremendous societal burden in terms of cost, morbidity, quality of life, and mortality. Yet, few people are able to obtain adequate or appropriate treatment.
This trial will compare the ability of two digital mental health interventions (DMHIs) to reduce depression and anxiety. One DMHI, called Mood Education App, provides information on depression and a broad range of strategies that are effective in improving symptoms. The other app, called VIRA, uses smartphone sensors to identify a few behavioral markers, including mobility patterns, physical activity, and sleep. The results of these sensed behavioral markers are used to give the participant behavior change recommendations through the Vira app that are expected to result in symptom improvement. The DMHI will include low intensity coaching, which includes one or more brief phone calls and communication via SMS text and in-app messaging. Both treatments are 8-weeks long.
The trial will be conducted within Rush University Medical Center's primary care and family medicine clinics, although recruitment be expanded beyond these clinics.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sensor-enabled digital mental health intervention (DMHI) | Experimental | Patients randomized to sensor-enabled DMHI condition will use Ksana Health's "Vira" mobile therapy platform with support from a study coach |
|
| Experimental: Control Treatment (CT) | Experimental | Participants randomized to the CT condition will use a Mood Education App designed by researchers at the University of Virginia to deliver psychoeducational content to help people self-manage symptoms of depression, anxiety, and stress. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| VIRA App | Other | Support from coach and using the VIRA app |
|
| Measure | Description | Time Frame |
|---|---|---|
| Patient Health Questionaire-9 (PHQ-9) | The PHQ-9 measures depression symptom severity on a scale of 0-27, with higher scores indicating greater symptom severity. | 12 weeks |
| Generalized Anxiety Disorder-7 (GAD-7) | The GAD-7 measures anxiety symptom severity on a scale of 0-21, with higher scores indicating greater symptoms severity | 12 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David C Mohr, PhD | Northwestern University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Rush University Medical Center Department of Psychiatry & Behavioral Sciences | Chicago | Illinois | 60612 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39563248 | Derived | Stiles-Shields C, Reyes KM, Lakhtakia T, Smith SR, Barnas OE, Gray EL, Krause CJ, Kruzan KP, Kwasny MJ, Mir Z, Panjwani S, Rothschild SK, Sanchez-Johnsen L, Winquist NW, Lattie EG, Allen NB, Reddy M, Mohr DC. A personal sensing technology enabled service versus a digital psychoeducation control for primary care patients with depression and anxiety: a pilot randomized controlled trial. BMC Psychiatry. 2024 Nov 19;24(1):828. doi: 10.1186/s12888-024-06284-z. |
Not provided
Not provided
Data will be shared through the NIMH Data Archive
Not provided
Data will be available 1 year after completion of the study.
Approval by NIMH Data Archive
Of 258 individuals assessed for eligibility, 130 met inclusion criteria and were randomized to treatment groups.
Recruitment took place between June 2022 and June 2023. Patients were recruited in-person from clinic-based sites and through community events (e.g., back-to-school fairs, wellness events); the electronic health record (EHR; MyChart/Epic); social media and other platforms; and through subject recruitment registries.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Sensor-enabled Digital Mental Health Intervention (DMHI) | Patients randomized to sensor-enabled DMHI condition will use Ksana Health's "Vira" mobile therapy platform with support from a study coach VIRA App: Support from coach and using the VIRA app |
| FG001 | Experimental: Control Treatment (CT) | Participants randomized to the CT condition will use a Mood Education App designed by researchers at the University of Virginia to deliver psychoeducational content to help people self-manage symptoms of depression, anxiety, and stress. Mood Education App: Support from mood education app |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Sensor-enabled Digital Mental Health Intervention (DMHI) | Patients randomized to sensor-enabled DMHI condition will use Ksana Health's "Vira" mobile therapy platform with support from a study coach VIRA App: Support from coach and using the VIRA app |
| BG001 | Experimental: Control Treatment (CT) |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Patient Health Questionaire-9 (PHQ-9) | The PHQ-9 measures depression symptom severity on a scale of 0-27, with higher scores indicating greater symptom severity. | Posted | Least Squares Mean | 95% Confidence Interval | score on a scale | 12 weeks |
|
Adverse event data were collected up to 12 weeks
Adverse events were monitored via assessments completed by participants (completed by all arms), application user feedback interviews (intervention arm-only), and interactions with the coaches (intervention arm-only). Questions regarding suicidal ideation were explicitly asked only on assessment questions (PHQ-9). The open-ended nature of interviews and coach interaction allowed for expression of suicidal thoughts or behaviors and as a result was monitored for indications of adverse events.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Sensor-enabled Digital Mental Health Intervention (DMHI) | Patients randomized to sensor-enabled DMHI condition will use Ksana Health's "Vira" mobile therapy platform with support from a study coach VIRA App: Support from coach and using the VIRA app |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Colleen Stiles-Shields, PhD | University of Illinois at Chicago | 312-413-1128 | ecss@uic.edu |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Mar 29, 2024 | Mar 5, 2025 | Prot_000.pdf |
| SAP | No | Yes | No | Statistical Analysis Plan | Mar 29, 2024 | Apr 3, 2025 | SAP_001.pdf |
| ICF | No | No | Yes | Informed Consent Form | May 15, 2023 | Apr 8, 2025 | ICF_002.pdf |
Not provided
| ID | Term |
|---|---|
| D003863 | Depression |
| D001008 | Anxiety Disorders |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D001523 | Mental Disorders |
Not provided
Not provided
Randomized Controlled Trial
Not provided
Not provided
Not provided
Not provided
| Mood Education App | Other | Support from mood education app |
|
Participants randomized to the CT condition will use a Mood Education App designed by researchers at the University of Virginia to deliver psychoeducational content to help people self-manage symptoms of depression, anxiety, and stress. Mood Education App: Support from mood education app |
| BG002 | Total | Total of all reporting groups |
| Participants |
|
| Age, Continuous | Median | Inter-Quartile Range | years |
|
| Sex/Gender, Customized | Count of Participants | Participants |
|
| Sex: Female, Male | Sex assigned at birth | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| Education | Count of Participants | Participants |
|
| Marital Status | Count of Participants | Participants |
|
| Household Income | Count of Participants | Participants |
|
|
|
| Primary | Generalized Anxiety Disorder-7 (GAD-7) | The GAD-7 measures anxiety symptom severity on a scale of 0-21, with higher scores indicating greater symptoms severity | Posted | Least Squares Mean | 95% Confidence Interval | score on a scale | 12 weeks |
|
|
|
| 0 |
| 65 |
| 0 |
| 65 |
| 0 |
| 65 |
| EG001 | Experimental: Control Treatment (CT) | Participants randomized to the CT condition will use a Mood Education App designed by researchers at the University of Virginia to deliver psychoeducational content to help people self-manage symptoms of depression, anxiety, and stress. Mood Education App: Support from mood education app | 0 | 65 | 0 | 65 | 0 | 65 |
Not provided
Not provided
| Week 8 |
|
| Week 12 |
|